Fanconi Anemia Caused by Biallelic Inactivation of BRCA2 Can Present With an Atypical Cancer Phenotype in Adulthood

Authors

Kara N Maxwell
Vishal Patel
Kevin T Nead
Shana Merrill
Dana Clark
Qinqin Jiang
Bradley Wubbenhorst
Kurt D'Andrea
Roger B Cohen
Susan M Domchek
Jennifer J D Morrissette
Roger A Greenberg
Daria V Babushok
Katherine L Nathanson

Publication Date

1-1-2023

Journal

Clinical Genetics

Abstract

Inherited biallelic pathogenic variants (PVs) in BRCA2 cause Fanconi Anemia complementation group D1 (FA-D1), a severe pediatric bone marrow failure and high-risk cancer syndrome. We identified biallelic BRCA2 PVs in a young adult with multiple basal cell carcinomas, adult-onset colorectal cancer and small cell neuroendocrine carcinoma, without bone marrow failure. No PVs were identified in any other known cancer susceptibility gene, and there was no evidence of reversion mosaicism. The proband's deceased sister had a classic FA-D1 presentation and was shown to carry the same biallelic BRCA2 PVs. A lymphoblastoid cell line derived from the proband demonstrated hypersensitivity to DNA damaging agents, and bone marrow showed aberrant RAD51 staining. Family expansion demonstrated the presence of BRCA2 related cancers in heterozygous family members. Our data highlight the striking phenotypic differences which can be observed within FA-D1 families and expands the clinical spectrum of FA-D1 to include adult presentation with a constellation of solid tumors not previously thought of as characteristic of Fanconi Anemia. Early recognition of this syndrome in a family could prevent further morbidity and mortality by implementation of hereditary breast and ovarian cancer screening and treatment strategies for heterozygous family members.

Keywords

Humans, BRCA2 Protein, Fanconi Anemia, Neoplasms, Siblings, Young Adult

Comments

Supplementary Materials

Data Availability Statement